Filtered By:
Condition: Hemorrhagic Stroke

This page shows you your search results in order of date. This is page number 15.

Order by Relevance | Date

Total 19785 results found since Jan 2013.

P060/83 Outcomes and safety of flow diverter stents for carotico-ophthalmic aneurysms
ConclusionFDS offers excellent outcomes and safety. Further intervention (routine antiplatelet testing, stent sizing software, reducing antiplatelet regime to 1 year) may optimise results.Disclosure of InterestNothing to disclose
Source: Journal of NeuroInterventional Surgery - August 21, 2023 Category: Neurosurgery Authors: Roberts, S., Jain, A., Islim, F., Nejadhamzeeigilani, H., Saleem, N., Goddard, T., Patankar, T. Tags: 1.1 HAEMORRHAGIC - Aneurysms Source Type: research

P064/122 Treatment of intracranial aneurysms with flow diversion in a real-world scenario - 10-year single center cohort
ConclusionOur series suggests that treatment with FD is feasible in a wide spectrum of cases, including aneurysms in different locations, sizes and morphology, ruptured and non-ruptured, reflecting a real-world scenario. Although available devices may differ, they seem to demonstrate comparable and adequate safety and effectiveness.Disclosure of InterestNothing to disclose
Source: Journal of NeuroInterventional Surgery - August 21, 2023 Category: Neurosurgery Authors: Maia, C., Cruz, L., Alves, M., Pamplona, J., Carvalho, R., Baptista, M., Camara, C. P. D., Pinheiro, C., Papoila, A., Lopes Dos Reis, J. J., Fragata, I. Tags: 1.1 HAEMORRHAGIC - Aneurysms Source Type: research

P067/132 Cerebral vasospasm treatment using comaneci device - registry study
ConclusionThe Comaneci device has the potential to serve as a first-line device for providing therapeutic benefit to patients with SAH and vasospasm. However, future prospective trials are required.Disclosure of InterestNothing to disclose
Source: Journal of NeuroInterventional Surgery - August 21, 2023 Category: Neurosurgery Authors: Hensler, J., Larsen, N., Christian, R., Nordmeyer, H., Breyer, T., Hesselmann, V., Jan, H., Jansen, O. Tags: 1.1 HAEMORRHAGIC - Aneurysms Source Type: research

P073/162 Clever: clinical evaluation of WEB 0.017 device in intracranial aneurysms. Final results for ruptured and enraptured aneurysms at 12 months
ConclusionThese results show good efficacy and safety results at 12 months, and no WEB related mortality, confirming safety and efficacy of WEB 0.017 use in unruptured and ruptured aneurysms.Disclosure of InterestIstvan Szikora has a consulting agreement with Microvention. I Szikora, Chr Cognard and L Spelle served as research coordinators for the CLEVER study
Source: Journal of NeuroInterventional Surgery - August 21, 2023 Category: Neurosurgery Authors: Szikora, I., Cognard, C., Costalat, V., Wodarg, F., Herbreteau, D., Fischer, S., Möhlenbruch, M., Chrysanti, P., Klisch, J., Rautio, R., Jussi, N., Ansgar, B., Downer, J., Bester, M., Velasco, S., Liebig, T., Byrne, J., Pierot, L., Spelle, L. Tags: 1.1 HAEMORRHAGIC - Aneurysms Source Type: research

P077/180 Silk vista baby flow diverter stent for unruptured distal brain aneurysms: a Brazilian retrospective observational study
ConclusionThe SVB has high rates of technical success and an acceptable safety profile. Distal aneurysms may occlude slower due to relative oversizing of the devices and coils could help to improve the occlusion rate.Disclosure of InterestNothing to disclose
Source: Journal of NeuroInterventional Surgery - August 21, 2023 Category: Neurosurgery Authors: Silva, J. M., Soares, G. M., Altikes, M., Junior, J. P., Coelho, A., Rezende, A. Tags: 1.1 HAEMORRHAGIC - Aneurysms Source Type: research

P082/226 Efficacy and safety of pipeline shield stents and flow-diverting stents without modified surfaces in patients with intracranial aneurysms
ConclusionThe treatment with Pipeline Shield stent was as safe as with FD stent without modified surfaces. However, they showed a greater occlusion efficacy during one-year evaluation period.Disclosure of Interestothing to disclose
Source: Journal of NeuroInterventional Surgery - August 21, 2023 Category: Neurosurgery Authors: Garcia, J., Rodriguez, A., Vera, D. D., Lara, J. J., Sandoval, O., Ferreira, C., Serrano, S., Vargas, O., Garcia, D. M. Tags: 1.1 HAEMORRHAGIC - Aneurysms Source Type: research

P089/268 Safety and efficacy of the fourth-generation Acandis Acclino Flex Plus stent in managing complex intracranial aneurysms
ConclusionThe AFP stent demonstrated feasibility and favourable safety and efficacy in the treatment of complex aneurysms. These results support its clinical use and highlight the need for further studies to evaluate its performance in different aneurysm subsets and to determine its specific role in the endovascular treatment of aneurysms.Disclosure of InterestCK serves as consultants for Acandis GmbH (Pforzheim, Germany) and proctor for MicroVention Inc./Sequent Medical (Aliso Viejo, CA, USA). David Zopfs is on the speaker’s bureau of Philips (Amsterdam, the Netherlands) and lecturer for Amboss GmbH (Cologne, Germany).
Source: Journal of NeuroInterventional Surgery - August 21, 2023 Category: Neurosurgery Authors: Goertz, L., Zopfs, D., Schönfeld, M., Schlamann, M., Kabbasch, C. Tags: 1.1 HAEMORRHAGIC - Aneurysms Source Type: research

P090/269 Comparative analysis between a second-generation (acandis acclino) and a first-generation (enterprise) stent system
ConclusionAdvanced stents offer reduced thromboembolic risk and comparable aneurysm occlusion to first-generation stents due to their flexible design and surface modification. These results support the clinical use of advanced stent systems, but further comparative studies are needed to conclusively evaluate the efficacy of stent-assisted coiling with the Acclino stent and other systems.Disclosure of InterestCK serves as consultants for Acandis GmbH (Pforzheim, Germany) and proctor for MicroVention Inc./Sequent Medical (Aliso Viejo, CA, USA). David Zopfs is on the speaker’s bureau of Philips (Amsterdam, the Netherlan...
Source: Journal of NeuroInterventional Surgery - August 21, 2023 Category: Neurosurgery Authors: Goertz, L., Zopfs, D., Schönfeld, M., Turowski, B., Schlamann, M., Kabbasch, C. Tags: 1.1 HAEMORRHAGIC - Aneurysms Source Type: research

P124/272 Initial encounter with a cutting-edge mobile head CT scanner (Somatom On.site) in a neuro-intensive care unit
ConclusionThe study demonstrates the clinical effectiveness of modern mobile CT scanners in neurointensive care units. The Somatom On.site provides sufficient image quality, saves time and supports timely decision making. The integration of mobile CT scanners in NICUs improves patient care and workflow. Prospective studies are needed to validate these findings and assess the long-term impact in NICUs and other units, such as stroke units.Disclosure of InterestCK serves as consultants for Acandis GmbH (Pforzheim, Germany) and proctor for MicroVention Inc./Sequent Medical (Aliso Viejo, CA, USA).
Source: Journal of NeuroInterventional Surgery - August 21, 2023 Category: Neurosurgery Authors: Goertz, L., Al-Sewaidi, Y., Habib, M., Ranft, A., Kabbasch, C. Tags: 3.1 OTHER - Innovation Source Type: research

P136/338 Intracranial vessel wall imaging - A tertiary centre initial experience
ConclusionOur centre’s experience recognises the role of MR-VWI in the imaging of ischaemic stroke, as well as its potential in management of acute unstable intracranial aneurysm. Clinical-radiological correlation remains imperative and emphasis is placed on understanding the potential technical pitfall of MR-VWI.Disclosure of InterestNothing to disclose for all authors
Source: Journal of NeuroInterventional Surgery - August 21, 2023 Category: Neurosurgery Authors: Chung, R.-E., Kow, K., Qayyum, N., Joseph, J., Jadun, C. K., Nayak, S., Srivastava, S., Majeed, U., Hashim, Z., Tsang, K. Tags: 2.1 ISCHEMIC - Logistics Source Type: research

P147/148 Transradial access for mechanical thrombectomy: technical outcomes at our institution
ConclusionThese results suggest that TRA is a viable alternative to TFA. In addition to the decreased incidence of haemorrhagic complications, TRA may also be particularly useful for stroke patients whose vascular anatomy presents a challenge for TFA (e.g., bovine aortic arch configuration and marked supra-aortic branch tortuosity).Disclosure of InterestNothing to disclose.
Source: Journal of NeuroInterventional Surgery - August 21, 2023 Category: Neurosurgery Authors: Queiros, H., Maia, C., Chaves, C., Nunes, C., Veiga, R., Machado, E. Tags: 2.3 ISCHEMIC - Treatment Source Type: research

P151/175 Direct aspiration with EMBOVAC - first clinical experience and clot composition (results the "PERFECT study)
ConclusionThis is the first clinical evaluation of EMBOVAC. Direct aspiration with EMBOVAC as first line therapy resulted in high rates of reperfusion and favorable clinical outcomes. Clot composition analysis can aid in better understanding of the stroke etiology and means for effective clot removal.Disclosure of InterestAcandis (OJ, CL, JF); Microvention (GM, CC, JF); Stryker (GM, CC, JF); Medtronic (GM, CC, JF); Surge2surgery (BG); MIVI (CC); Phenox (CL, JF); Penumbra (CL, JF); GSK (AS); German Ministry of Science & Education and Economy & Innovation, EU, Hamburgische Investitions-/Förderbank, Philips, B...
Source: Journal of NeuroInterventional Surgery - August 21, 2023 Category: Neurosurgery Authors: Lobotesis, K., Jansen, O., Marnat, G., Gory, B., Nordmeyer, H., Eckert, B., Alessandro, P., Cognard, C., Loehr, C., Bracco, S., Schaefer, A., Macera, A., Fiehler, J., Doyle, K., Piano, M. Tags: 2.3 ISCHEMIC - Treatment Source Type: research

P152/178 Safety and efficiency of bridging i.v. thrombolysis in M2 occlusions: a propensity-score-matched registry cohort study
ConclusionIn M2-occlusions, MT+IVT was not associated with increased risk of sICH. Patients receiving MT+IVT had lower 90d-mRS and a lower increase in mRS pre-stroke to 90d. However, probability of functional independence and rates of successful recanalization were similar compared to matched controls.Disclosure of InterestHK has financial interest in Eppdata GmbH.GT received fees as consultant and lecturer from Acandis, Alexion, Amarin, Boehringer Ingelheim, Bayer, BMS/Pfizer, Daiichii Sankyo and Portola. He serves in the board of the TEA Stroke Study and of ESO.JF is consultant for Cerenovus, Medtronic, Microvention, Pen...
Source: Journal of NeuroInterventional Surgery - August 21, 2023 Category: Neurosurgery Authors: Kniep, H., Meyer, L., Broocks, G., Bechstein, M., Faizy, T., Winkelmeier, L., Brekenfeld, C., Flottmann, F., Paula Hanning, U. M., Thomalla, G., Fiehler, J., Gellissen, S. Tags: 2.3 ISCHEMIC - Treatment Source Type: research

P156/208 Association between arterial diameter and outcome in acute M2 occlusive ischemic stroke patients treated with endovascular thrombectomy
ConclusionThis study demonstrated that the lowest quartile of M2 diameter was associated with procedural complication in the acute M2 occlusion patients treated with EVT. However, clinical outcome was not differed.Disclosure of InterestNothing to disclose
Source: Journal of NeuroInterventional Surgery - August 21, 2023 Category: Neurosurgery Authors: Kim, J. Y., Kim, D. Y., Kang, J., Kim, B. J., Han, M.-K., Bae, H.-J., Baik, S. H., Jung, C. Tags: 2.3 ISCHEMIC - Treatment Source Type: research

P160/223 Acute stroke with treatment of tandem lesions under triple antiplatelet therapy: procedural saftey, stent patency and outcome at 90 days
ConclusionTL treatment under triple AP was safe in our experience, resulting in a low rate of restenosis and with favorable outcome in 92%. The influence of comorbidities on restenosis could be negligible within the described follow-up period.Disclosure of InterestPhilipp von Gottberg: Nothing to disclose.Ali Khanafer: Nothing to discloseVictoria Hellstern: Proctering for phenox GmbH.Alexandru Cimpocca: Nothing to disclose.Hans Henkes: Proctoring for phenox GmbH, Co-Founder and Co-Owner of CONTARA GmbH
Source: Journal of NeuroInterventional Surgery - August 21, 2023 Category: Neurosurgery Authors: Philipp, V. G., Khanafer, A., Hellstern, V., Cimpoca, A., Bäzner, H., Henkes, H. Tags: 2.3 ISCHEMIC - Treatment Source Type: research